Ibrutinib impairs the phagocytosis of rituximab-coated leukemic cells from chronic lymphocytic leukemia patients by human macrophages

Ibrutinib impairs the phagocytosis of rituximab-coated leukemic cells from chronic lymphocytic leukemia patients by human macrophages

Saved in:
Bibliographic Details
Published in:Haematologica (Roma) Vol. 100; no. 4; pp. e140 - e142
Main Authors: Borge, Mercedes, Belén Almejún, María, Podaza, Enrique, Colado, Ana, Fernández Grecco, Horacio, Cabrejo, María, Bezares, Raimundo F, Giordano, Mirta, Gamberale, Romina
Format: Journal Article
Language:English
Published: Italy Ferrata Storti Foundation 01-04-2015
Subjects:
Antibodies, Monoclonal, Murine-Derived - pharmacology
Antibodies, Monoclonal, Murine-Derived - therapeutic use
Antineoplastic Agents - pharmacology
Antineoplastic Agents - therapeutic use
Cytophagocytosis - immunology
Humans
Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell - immunology
Macrophages - drug effects
Macrophages - immunology
Online Only
Rituximab
ibrutinib
rituximab-dependent
phagocytosis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0390-6078
1592-8721
DOI:10.3324/haematol.2014.119669